{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:51:47Z","timestamp":1771930307249,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T00:00:00Z","timestamp":1329177600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1472-6947-12-7","type":"journal-article","created":{"date-parts":[[2012,2,14]],"date-time":"2012-02-14T19:14:03Z","timestamp":1329246843000},"source":"Crossref","is-referenced-by-count":29,"title":["Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations"],"prefix":"10.1186","volume":"12","author":[{"given":"Matthew D","family":"Krasowski","sequence":"first","affiliation":[]},{"given":"Louis E","family":"Penrod","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2012,2,14]]},"reference":[{"key":"463_CR1","volume-title":"To err is human: building a safe health system","author":"LT Kohn","year":"2000","unstructured":"Kohn LT, Corrigan J, Donaldson MS: To err is human: building a safe health system. 2000, Washington, DC: National Academy Press"},{"key":"463_CR2","volume-title":"Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century","author":"(U.S.) IoM","year":"2001","unstructured":"(U.S.) IoM: Committee on Quality of Health Care in America. Crossing the quality chasm: a new health system for the 21st century. 2001, Washington, DC: National Academy Press"},{"key":"463_CR3","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1136\/jamia.2001.0080299","volume":"8","author":"DW Bates","year":"2001","unstructured":"Bates DW, Cohen M, Leape LL, Overhage JM, Shabot MM, Sheridan T: Reducing the frequency of errors in medicine using information technology. J Am Med Inform Assoc. 2001, 8: 299-308. 10.1136\/jamia.2001.0080299.","journal-title":"J Am Med Inform Assoc"},{"key":"463_CR4","doi-asserted-by":"publisher","first-page":"2741","DOI":"10.1001\/archinte.160.18.2741","volume":"160","author":"JM Teich","year":"2000","unstructured":"Teich JM, Merchia PR, Schmiz JL, Kuperman GJ, Spurr CD, Bates DW: Effects of computerized physician order entry on prescribing practices. Arch Intern Med. 2000, 160: 2741-2747. 10.1001\/archinte.160.18.2741.","journal-title":"Arch Intern Med"},{"key":"463_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1001\/jama.293.10.1197","volume":"293","author":"R Koppel","year":"2005","unstructured":"Koppel R, Metlay JP, Cohen A, Abaluck B, Localio AR, Kimmel SE, Strom BL: Role of computerized physician order entry system in facilitating medication errors. JAMA. 2005, 293: 1197-1203. 10.1001\/jama.293.10.1197.","journal-title":"JAMA"},{"key":"463_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1197\/jamia.M1411","volume":"11","author":"RG Berger","year":"2004","unstructured":"Berger RG, Kichak JP: Computerized physician order entry: helpful or harmful?. J Am Med Inform Assoc. 2004, 11: 100-103.","journal-title":"J Am Med Inform Assoc"},{"key":"463_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1197\/jamia.M1471","volume":"11","author":"JS Ash","year":"2004","unstructured":"Ash JS, Berg M, Coiera E: Some unintended consequences of information technology in health care: the nature of patient care information system-related errors. J Am Med Inform Assoc. 2004, 11: 104-112.","journal-title":"J Am Med Inform Assoc"},{"key":"463_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cca.2006.08.026","volume":"377","author":"A Dasgupta","year":"2007","unstructured":"Dasgupta A: Usefulness of monitoring free (unbound) concentrations of therapeutic drugs in patient management. Clin Chim Acta. 2007, 377: 1-13. 10.1016\/j.cca.2006.08.026.","journal-title":"Clin Chim Acta"},{"key":"463_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00007691-199904000-00003","volume":"21","author":"C Fedler","year":"1999","unstructured":"Fedler C, Stewart MJ: Plasma total phenytoin: a possibly misleading test in developing countries. Ther Drug Monit. 1999, 21: 15-160.","journal-title":"Ther Drug Monit"},{"key":"463_CR10","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/BF01059685","volume":"5","author":"E Martin","year":"1977","unstructured":"Martin E, Tozer TN, Sheiner LB, Riegelman S: The clinical pharmacokinetics of phenytoin. J Pharmacokinet Biopharm. 1977, 5: 579-596. 10.1007\/BF01059685.","journal-title":"J Pharmacokinet Biopharm"},{"key":"463_CR11","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1111\/j.1365-2125.2005.02529.x","volume":"61","author":"E Perucca","year":"2006","unstructured":"Perucca E: Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006, 61: 246-255. 10.1111\/j.1365-2125.2005.02529.x.","journal-title":"Br J Clin Pharmacol"},{"key":"463_CR12","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN, Berry DJ, Bourgeois BFD, Cloyd JC, Glauser TA, Johannessen SI, Tomson T, Perucca E: Antiepileptic drugs - best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia. 2008, 49: 1239-1276. 10.1111\/j.1528-1167.2008.01561.x.","journal-title":"Epilepsia"},{"key":"463_CR13","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1515\/CCLM.2002.172","volume":"40","author":"A Dasgupta","year":"2002","unstructured":"Dasgupta A: Clinical utility of free drug monitoring. Clin Chem Lab Med. 2002, 40: 986-993. 10.1515\/CCLM.2002.172.","journal-title":"Clin Chem Lab Med"},{"key":"463_CR14","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00007691-200206000-00009","volume":"24","author":"HL Banh","year":"2002","unstructured":"Banh HL, Burton ME, Sperling MR: Interpatient and intrapatient variability in phenytoin protein binding. Ther Drug Monit. 2002, 24: 379-385. 10.1097\/00007691-200206000-00009.","journal-title":"Ther Drug Monit"},{"key":"463_CR15","first-page":"312","volume":"62","author":"LM Profeta","year":"1995","unstructured":"Profeta LM, Bradbury K, Mehl B: Pharmacokinetic considerations in phenytoin pharmacotherapy: preventing overdoses and underdoses. Mt Sinai J Med. 1995, 62: 312-314.","journal-title":"Mt Sinai J Med"},{"key":"463_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.seizure.2007.12.007","volume":"17","author":"K Chan","year":"2008","unstructured":"Chan K, Beran RG: Value of therapeutic drug level monitoring and unbound (free) levels. Seizure. 2008, 17: 572-575. 10.1016\/j.seizure.2007.12.007.","journal-title":"Seizure"},{"key":"463_CR17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/106002809603000301","volume":"30","author":"ME Mlynarek","year":"1996","unstructured":"Mlynarek ME, Peterson EL, Zarowitz BJ: Predicting unbound phenytoin concentrations in the critically ill neurosurgical patient. Ann Pharmacother. 1996, 30: 219-223.","journal-title":"Ann Pharmacother"},{"key":"463_CR18","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00007691-200106000-00014","volume":"23","author":"MS Monaghan","year":"2001","unstructured":"Monaghan MS, Marx MA, Olsen KM, Turner PD, Bergman KL: Correlation and prediction of phenytoin protein binding using standard laboratory parameters in patients after renal transplantation. Ther Drug Monit. 2001, 23: 263-267. 10.1097\/00007691-200106000-00014.","journal-title":"Ther Drug Monit"},{"key":"463_CR19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/clinchem\/46.8.1132","volume":"46","author":"M Burt","year":"2000","unstructured":"Burt M, Anderson DC, Kloss J, Apple FS: Evidence-based implementation of free phenytoin therapeutic drug monitoring. Clin Chem. 2000, 46: 1132-1135.","journal-title":"Clin Chem"},{"key":"463_CR20","doi-asserted-by":"publisher","first-page":"517","DOI":"10.3349\/ymj.2009.50.4.517","volume":"50","author":"JM Hong","year":"2009","unstructured":"Hong JM, Choi YC, Kim WJ: Differences between the measured and calculated free serum phenytoin concentrations in epileptic patients. Yonsei Med J. 2009, 50: 517-520. 10.3349\/ymj.2009.50.4.517.","journal-title":"Yonsei Med J"},{"key":"463_CR21","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/01.ftd.0000173373.12569.c7","volume":"27","author":"GA McMillin","year":"2005","unstructured":"McMillin GA, Juenke J, Dasgupta A: Effect of ultrafiltrate volume on determination of free phenytoin concentration. Ther Drug Monit. 2005, 27: 630-633. 10.1097\/01.ftd.0000173373.12569.c7.","journal-title":"Ther Drug Monit"},{"key":"463_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/00007691-200104000-00009","volume":"23","author":"WL Roberts","year":"2001","unstructured":"Roberts WL, Annesley TM, De BK, Moulton L, Juenke JM, Moyer TP: Performance characteristics of four free phenytoin immunoassays. Ther Drug Monit. 2001, 23: 148-154. 10.1097\/00007691-200104000-00009.","journal-title":"Ther Drug Monit"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-12-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-12-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T12:07:56Z","timestamp":1593691676000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-12-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,14]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["463"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-12-7","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,14]]},"article-number":"7"}}